Latest Ratios: P/E Ratio 36.4x · EV/EBITDA 29.8x · ROE 50.5%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $549.1B | $416.1B | $272.8B | $298.3B | $217.5B | $326.7B | $204.4B | $124.8B | $66.4B | $75.0B | $48.0B |
| Enterprise Value | $539.6B | $407.5B | $264.7B | $295.9B | $214.5B | $324.4B | $203.0B | $124.3B | $66.3B | $75.8B | $48.4B |
| P/E Ratio → | 36.37 | 43.30 | 36.02 | 38.06 | 38.67 | 55.52 | 57.51 | 48.36 | 26.29 | 35.40 | 32.62 |
| P/S Ratio | 12.48 | 12.74 | 9.65 | 10.82 | 10.27 | 17.56 | 14.62 | 10.56 | 6.06 | 8.37 | 6.98 |
| P/B Ratio | 25.34 | 21.21 | 14.76 | 22.17 | 24.68 | 32.22 | 14.74 | 9.91 | 5.70 | 6.96 | 4.89 |
| P/FCF | 23.30 | 37.53 | 30.03 | 91.86 | 30.11 | 32.99 | 56.36 | 50.64 | 26.94 | 52.08 | 35.78 |
| P/OCF | 38.91 | 32.87 | 24.43 | 54.80 | 25.62 | 30.13 | 44.17 | 34.14 | 20.10 | 41.71 | 28.80 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 12.48 | 9.37 | 10.74 | 10.13 | 17.43 | 14.52 | 10.52 | 6.05 | 8.46 | 7.04 |
| EV / EBITDA | 29.80 | 33.06 | 26.63 | 30.11 | 30.27 | 46.29 | 44.70 | 38.39 | 19.56 | 27.45 | 25.20 |
| EV / EBIT | 42.83 | 35.73 | 28.79 | 32.04 | 32.91 | 47.98 | 50.01 | 44.37 | 22.24 | 30.97 | 27.99 |
| EV / FCF | — | 36.77 | 29.15 | 91.13 | 29.69 | 32.75 | 55.98 | 50.47 | 26.90 | 52.61 | 36.09 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 52.8% | 52.8% | 49.8% | 50.2% | 49.5% | 51.9% | 47.4% | 43.4% | 44.8% | 43.5% | 42.7% |
| Operating Margin | 34.6% | 34.6% | 31.9% | 32.8% | 30.7% | 35.1% | 29.0% | 23.6% | 27.1% | 26.2% | 22.7% |
| Net Profit Margin | 29.4% | 29.4% | 26.8% | 28.4% | 26.6% | 31.6% | 25.4% | 21.9% | 23.7% | 23.1% | 21.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 50.5% | 50.5% | 47.4% | 70.4% | 59.4% | 49.0% | 26.9% | 21.4% | 23.1% | 20.1% | 16.2% |
| ROA | 19.4% | 19.4% | 17.1% | 20.6% | 16.9% | 20.5% | 14.2% | 12.1% | 13.5% | 11.7% | 9.7% |
| ROIC | 78.8% | 78.8% | 62.9% | 80.3% | 71.8% | 48.4% | 24.6% | 16.1% | 16.6% | 15.2% | 13.6% |
| ROCE | 41.2% | 41.2% | 34.6% | 43.1% | 35.9% | 33.9% | 21.0% | 16.3% | 18.9% | 16.2% | 13.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.22 | 0.22 | 0.25 | 0.34 | 0.48 | 0.45 | 0.34 | 0.25 | 0.26 | 0.28 | 0.34 |
| Debt / EBITDA | 0.36 | 0.36 | 0.47 | 0.47 | 0.60 | 0.65 | 1.03 | 0.96 | 0.89 | 1.10 | 1.73 |
| Net Debt / Equity | — | -0.43 | -0.44 | -0.18 | -0.34 | -0.23 | -0.10 | -0.03 | -0.01 | 0.07 | 0.04 |
| Net Debt / EBITDA | -0.69 | -0.69 | -0.81 | -0.24 | -0.42 | -0.34 | -0.30 | -0.13 | -0.03 | 0.28 | 0.21 |
| Debt / FCF | — | -0.77 | -0.89 | -0.73 | -0.42 | -0.24 | -0.38 | -0.17 | -0.04 | 0.53 | 0.31 |
| Interest Coverage | — | — | 59.83 | 60.72 | 107.19 | 123.81 | 93.76 | 76.57 | 71.26 | 42.55 | 45.51 |
Net cash position: cash ($12.9B) exceeds total debt ($4.4B)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.26 | 1.26 | 1.53 | 1.50 | 1.28 | 1.48 | 2.41 | 2.58 | 2.78 | 2.80 | 2.61 |
| Quick Ratio | 0.79 | 0.79 | 0.95 | 0.91 | 0.86 | 1.03 | 1.68 | 1.73 | 1.81 | 1.84 | 1.74 |
| Cash Ratio | 0.55 | 0.55 | 0.64 | 0.43 | 0.41 | 0.62 | 1.11 | 1.01 | 1.06 | 1.04 | 1.24 |
| Asset Turnover | — | 0.65 | 0.58 | 0.69 | 0.58 | 0.62 | 0.51 | 0.52 | 0.54 | 0.49 | 0.40 |
| Inventory Turnover | 1.35 | 1.35 | 1.21 | 1.44 | 1.39 | 1.64 | 1.52 | 1.66 | 1.65 | 1.65 | 1.35 |
| Days Sales Outstanding | — | 51.61 | 70.30 | 96.11 | 121.48 | 89.37 | 87.03 | 88.02 | 80.07 | 89.76 | 64.81 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.5% | 0.6% | 0.9% | 0.8% | 1.2% | 0.4% | 0.5% | 1.1% | 0.9% | 0.7% | 0.9% |
| Payout Ratio | 26.5% | 26.5% | 32.4% | 30.0% | 45.5% | 23.3% | 30.0% | 51.1% | 23.0% | 25.0% | 30.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.7% | 2.3% | 2.8% | 2.6% | 2.6% | 1.8% | 1.7% | 2.1% | 3.8% | 2.8% | 3.1% |
| FCF Yield | 4.3% | 2.7% | 3.3% | 1.1% | 3.3% | 3.0% | 1.8% | 2.0% | 3.7% | 1.9% | 2.8% |
| Buyback Yield | 1.2% | 1.4% | 0.2% | 0.3% | 2.1% | 2.6% | 0.6% | 0.3% | 1.7% | 0.7% | 0.8% |
| Total Shareholder Yield | 1.7% | 2.0% | 1.1% | 1.1% | 3.3% | 3.0% | 1.1% | 1.4% | 2.6% | 1.4% | 1.8% |
| Shares Outstanding | — | $389M | $394M | $394M | $398M | $410M | $419M | $422M | $426M | $432M | $428M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Bull/bear thesis, analyst target revisions, and earnings execution.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ASML stock.
ASML Holding N.V.'s current P/E ratio is 36.4x. The historical average is 40.2x. This places it at the 62th percentile of its historical range.
ASML Holding N.V.'s current EV/EBITDA is 29.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 26.0x.
ASML Holding N.V.'s return on equity (ROE) is 50.5%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 25.2%.
Based on historical data, ASML Holding N.V. is trading at a P/E of 36.4x. This is at the 62th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
ASML Holding N.V.'s current dividend yield is 0.51% with a payout ratio of 26.5%.
ASML Holding N.V. has 52.8% gross margin and 34.6% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
ASML Holding N.V.'s Debt/EBITDA ratio is 0.4x, indicating low leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Export control revenue concentration
Premium Multiple Prices Lithography Monopoly
ASML trades at 59.85x trailing earnings and 45.41x EV/EBITDA versus roughly 49-52x P/E for WFE peers AMAT, LRCX and KLAC, implying the market pays a meaningful premium for a franchise whose 57.4% gross margin in 2026Q3 leads the group, as reported in recent filings.
The compression from 59.85x trailing P/E to 42.63x forward P/E and 45.41x to 32.41x forward EV/EBITDA embeds an expectation of continued high-single to low-double-digit earnings expansion, consistent with the deferred revenue rebuild to $9.3B, but it also assumes the 2026Q3 mix-driven margin peak is a floor rather than a ceiling. Notably the P/B of 29.34x sits almost exactly at Lam Research's 29.01x despite ASML's lower reported ROE, suggesting the earnings premium is not being extrapolated into book-value terms — a discipline that may reflect skepticism about the durability of the current margin envelope given the skipped forward guidance.
ROIC Triples on Mix, Not Leverage
According to reported figures, ASML's ROIC climbed from 8.5% in 2024Q1 to 24.6% in 2026Q3 while ROE rose from 8.9% to 23.1%, a compounding trajectory driven predominantly by the 1,810 basis point operating margin expansion rather than by balance-sheet or turnover effects.
The decomposition matters: with debt-to-equity falling from 0.33 to 0.09, ROE in 2026Q3 (23.1%) actually trails ROIC (24.6%), which in a near-unlevered company means the return story is almost entirely a margin and asset-turnover story — asset turnover roughly doubled from 0.13 to 0.22 over the period. That is the healthy version of return expansion, but it also implies mean reversion risk if the EUV/High-NA mix share normalizes; investors should note that ROIC of 24.6% still sits below the 44.0% (KLAC) and 65.2% (LRCX) peer marks, so the premium multiple is being justified by scarcity, not by superior realized capital efficiency.
Working Capital Cycle Compresses Sharply
As reported in recent financial statements, ASML's days sales outstanding contracted from 114 in 2024Q1 to 65 in 2026Q3 while inventory days fell from 342 to 217, a working capital release broadly consistent with accelerated High-NA acceptance timing and disciplined build-to-order execution.
A 52% reduction in DSO alongside rising revenue is unusual for a capital-equipment vendor and appears to reflect both the customer down-payment structure and faster formal acceptance of shipped systems; the concurrent inventory drawdown suggests ASML is no longer pre-building ahead of demand, which typically precedes either order softness or delivery acceleration. Days payable and cash conversion cycle are not populated in the supplied data, so supplier-side float cannot be assessed; the key judgment call is that the efficiency gain is partly contractual (prepayment terms) rather than purely operational, so it may not persist unchanged if booking prepayment cadence shifts.
Balance Sheet Delevered Into Cycle Peak
ASML's debt-to-equity ratio compressed from 0.33 in 2024Q1 to 0.09 in 2026Q3 and D/EBITDA fell from 2.89x to 0.36x over the same window, placing leverage well below the 0.30-0.93 range observed across WFE peers, per company filings.
With debt reduced to approximately $2.0B against a current ratio of 1.49 and a quick ratio that has crossed above 1.00 for the first time in the observed series, debt service capacity is effectively unconstrained; the historical interest coverage prints (157x to 3,201x where available) imply interest expense is immaterial to earnings. The nuance for analysts is that a portion of the balance-sheet expansion is customer-float driven — deferred revenue roughly tripled year over year — so the apparent fortress is partly funded by advance payments rather than retained earnings, and the associated obligation is delivery of systems, not repayment, which is a materially better form of liability but still timing-sensitive.
Return Profile Trails Cheaper WFE Peers
Peer comparison highlights a tension: ASML's TTM ROE of approximately 50.5% remains below KLA's 85.4% and Lam Research's 67.0%, and its ROIC of 24.6% lags KLAC's 44.0% and LRCX's 65.2%, yet its 59.85x P/E exceeds the entire group, per current market data.
Two explanations are defensible and should be weighed separately: the ROE gap is partly a function of peers' heavier buyback-financed equity shrinkage (KLA at 0.93 D/E carries more financial leverage into its return metrics), whereas ASML has delevered, which mechanically suppresses ROE even as ROIC improves. The residual premium is therefore a scarcity rent on EUV exclusivity rather than a return-on-capital edge, and it is most vulnerable to the scenario in which export restrictions cap the addressable DUV and China-exposed revenue base — the segment that historically supplied volume stability beneath the EUV margin layer.
Trailing P/E Is the Misapplied Ratio
The 59.85x trailing P/E is the ratio most commonly misapplied to ASML, because fast-shipment revenue recognition and customer-advance timing decouple reported earnings from economic delivery, making a mid-cycle forward EV/EBITDA or backlog-covered earnings multiple the more defensible valuation anchor, based on current market multiples.
The empirical case is in ASML's own series: net margin swung from 23.1% to 42.5% and FCF margin whipsawed between -29.7% and 108.8% across ten quarters, so any four-quarter trailing earnings window embeds an arbitrary slice of the acceptance and prepayment cycle rather than a true earning power. The PEG of 2.33 compounds the error, since PEG presumes smooth growth while ASML's revenue is lumpy and booking-driven. Analysts should instead normalize net margin to a mid-cycle 33-38% band (below the current 42.5% peak mix) and anchor on forward EV/EBITDA, using deferred revenue as a check on earnings quality rather than treating the elevated trailing multiple as a signal of durability.